Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 967374Generated: October 31, 2026

Methanesulfonyl chloride → HCID 10233130, compound

https://huagongshe.com/reaction/967374

Reaction equation

Participants

RoleNameHCIDCharge
ReactantMethanesulfonyl chlorideHCID 31297—
ReactantDiisopropylethylamineHCID 81531—
ReactantMethanesulfonateHCID 85257—
ReactantHCID 22293859HCID 22293859—
Reactant1-(3-Hydroxy-propyl)-3-(4-trifluoromethyl-phenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl esterHCID 68461192—
SolventDimethylformamideHCID 6228—
SolventDichloromethaneHCID 6344—
SolventTrifluoroacetic acidHCID 6422—
SolventEthyl AcetateHCID 8857—
ProductHCID 10233130HCID 1023313014%

Reaction Conditions

Temperature0 °C

Reaction Steps

1-(3-Hydroxy-propyl)-3-(4-trifluoromethyl-phenyl)-1,4,6,7-tetrahydro-pyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester (268 mg, 0.63 mmol) was dissolved in CH2Cl2 (10 mL) and TFA (10 mL). The mixture was stirred for 1 h then concentrated to dryness. The residue was dissolved in CH2Cl2 (4.0 mL), cooled to 0° C. and treated with i-Pr2NEt (0.36 mL, 2.1 mmol), followed by methanesulfonyl chloride (0.16 mL, 2.1 mmol). The reaction mixture was stirred for 4 h, then diluted with EtOAc (200 mL) and washed with saturated aqueous NaHCO3 (2×25 mL). The washes were extracted with EtOAc (2×25 mL). The combined extracts were dried over Na2SO4 and concentrated. A portion of the crude mesylate (197 mg, ca. 0.41 mmol) was combined with (2-oxo-3-piperidin-4-yl-2,3-dihydro-benzoimidazol-1-yl)-acetonitrile (321 mg, 1.25 mmol) in CH2Cl2 (2.0 mL) and DMF (0.5 mL). The resulting mixture was treated with i-Pr2NEt (0.22 mL, 1.3 mmol) and stirred for 60 h. The reaction mixture was partitioned between EtOAc (150 mL) and saturated aqueous NaHCO3 (75 mL). The EtOAc layer was washed with H2O (2×75 mL), and brine (75 mL). The combined washes were extracted with EtOAc (3×50 mL). The combined extracts were dried over Na2SO4 and concentrated. Purification of the residue by preparative TLC (silica, 1% MeOH/CH2Cl2 then 25% acetone/CH2Cl2) gave 37 mg (14%) of the title compound. HPLC (reverse phase conditions), tR=2.94 min. MS (electrospray): m/z calculated for C31H35F3N7O3S [M++H] 642.25, found 642.25. 1H NMR (CDCl3, 400 MHz): 7.73 and 7.76 (A and B of AA′BB′ Jab=8.2 Hz, 4H), 7.26-7.05 (m, 4H), 4.81 (s, 2H), 4.56 (s, 2H), 4.26 (m, 1H), 4.15 (t, J=6.8 Hz, 2H), 3.70 (t, J=5.8 Hz, 2H), 3.03 (br d, J=11.1 Hz, 2H), 2.95 (t, J=5.7 Hz, 2H), 2.91 (s, 3H), 2.43 (m, 4H), 2.12 (m, 4H), 1.82 (br d, J=9.9 Hz, 2H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06953793B2
Source datasetuspto-grants-2005_10
ORD IDord-cce5c01f995944ff99bd96ceefc15c70
Source noteuspto-grants-2005_10